pdufa.bio

Canalevia-CA1

Updated ยทnext FDA decision on the calendar

Canalevia-CA1 The FDA approved it on Apr 29, 2026. 1 FDA decision on record below. Every date links its source.

JAGX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Apr 29, 2026 ✓ ApprovedJAGX

Questions

When is Canalevia-CA1's next FDA decision or readout?

No upcoming catalyst is on our calendar for Canalevia-CA1; 1 FDA decision is on record below.

What happened at Canalevia-CA1's most recent FDA decision?

On Apr 29, 2026 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.

Has Canalevia-CA1 been approved by the FDA?

Yes. The FDA approved an application for Canalevia-CA1 on Apr 29, 2026; the decision page linked above carries the source.

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.